Published online 25 April 2005 doi:10.1084/jem.20042309
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 201, Number 9, 1375-1383
Identification of proteoglycans as the APRIL-specific binding partners
Karine Ingold1,
Adrian Zumsteg1,
Aubry Tardivel1,
Bertrand Huard2,
Quynh-Giao Steiner1,
Teresa G. Cachero3,
Fang Qiang3,
Leonid Gorelik3,
Susan L. Kalled3,
Hans Acha-Orbea1,
Paul D. Rennert3,
Jürg Tschopp1, and
Pascal Schneider1
1 Department of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland
2 Department of Dermatology, University of Geneva Medical Center, CH-1211 Geneva 4, Switzerland
3 Biogen Idec, Cambridge, MA 02142
CORRESPONDENCE Pascal Schneider: pascal.schneider{at}unil.ch
B cell activating factor of the tumor necrosis factor (TNF) family (BAFF) and a proliferation-inducing ligand (APRIL) are closely related ligands within the TNF superfamily that play important roles in B lymphocyte biology. Both ligands share two receptorstransmembrane activator and calcium signalmodulating cyclophilin ligand interactor (TACI) and B cell maturation antigen (BCMA)that are predominantly expressed on B cells. In addition, BAFF specifically binds BAFF receptor, whereas the nature of a postulated APRIL-specific receptor remains elusive. We show that the TNF homology domain of APRIL binds BCMA and TACI, whereas a basic amino acid sequence (QKQKKQ) close to the NH2 terminus of the mature protein is required for binding to the APRIL-specific "receptor." This interactor was identified as negatively charged sulfated glycosaminoglycan side chains of proteoglycans. Although T cell lines bound little APRIL, the ectopic expression of glycosaminoglycan-rich syndecans or glypicans conferred on these cells a high binding capacity that was completely dependent on APRIL's basic sequence. Moreover, syndecan-1positive plasma cells and proteoglycan-rich nonhematopoietic cells displayed high specific, heparin-sensitive binding to APRIL. Inhibition of BAFF and APRIL, but not BAFF alone, prevented the survival and/or the migration of newly formed plasma cells to the bone marrow. In addition, costimulation of B cell proliferation by APRIL was only effective upon APRIL oligomerization. Therefore, we propose a model whereby APRIL binding to the extracellular matrix or to proteoglycan-positive cells induces APRIL oligomerization, which is the prerequisite for the triggering of TACI- and/or BCMA-mediated activation, migration, or survival signals.
Abbreviations used: APRIL, a proliferation-inducing ligand; BAFF, B cell activating factor of the TNF family; BAFF-R, BAFF receptor; BCMA, B cell maturation antigen; COMP, cartilage matrix oligomeric protein; EDA, ectodysplasin A; TACI, transmembrane activator and calcium signalmodulating cyclophilin ligand interactor.
A. Zumsteg's present address is Institute for Biochemistry and Genetics, University of Basel, CH-4058 Basel, Switzerland.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Hardenberg, G., Fernandez, L., Hendriks, J., Chebli, K., Jacquet, C., Sitbon, M., Hahne, M., Medema, J. P.
(2008). APRIL facilitates viral-induced erythroleukemia but is dispensable for T cell immunity and lymphomagenesis. J. Leukoc. Biol.
84: 380-388
[Abstract]
[Full Text]
-
Roosnek, E., Schneider, P., Huard, B.
(2008). Heparan sulfate proteoglycans, Fc receptors, and DC suppression. Blood
112: 915-916
[Full Text]
-
Hsieh, S.-L.
(2008). Response: Decoy receptor 3 (DcR3), a pleiotropic immunomodulator. Blood
112: 916-917
[Full Text]
-
Geffroy-Luseau, A., Jego, G., Bataille, R., Campion, L., Pellat-Deceunynck, C.
(2008). Osteoclasts support the survival of human plasma cells in vitro. Int Immunol
20: 775-782
[Abstract]
[Full Text]
-
Benson, M. J., Dillon, S. R., Castigli, E., Geha, R. S., Xu, S., Lam, K.-P., Noelle, R. J.
(2008). Cutting Edge: The Dependence of Plasma Cells and Independence of Memory B Cells on BAFF and APRIL. J. Immunol.
180: 3655-3659
[Abstract]
[Full Text]
-
Belnoue, E., Pihlgren, M., McGaha, T. L., Tougne, C., Rochat, A.-F., Bossen, C., Schneider, P., Huard, B., Lambert, P.-H., Siegrist, C.-A.
(2008). APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood
111: 2755-2764
[Abstract]
[Full Text]
-
Cancro, M. P.
(2008). Different partners in different places?. Blood
111: 975-975
[Full Text]
-
Bossen, C., Cachero, T. G., Tardivel, A., Ingold, K., Willen, L., Dobles, M., Scott, M. L., Maquelin, A., Belnoue, E., Siegrist, C.-A., Chevrier, S., Acha-Orbea, H., Leung, H., Mackay, F., Tschopp, J., Schneider, P.
(2008). TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts. Blood
111: 1004-1012
[Abstract]
[Full Text]
-
Gonzalez-Garcia, I., Rodriguez-Bayona, B., Mora-Lopez, F., Campos-Caro, A., Brieva, J. A.
(2008). Increased survival is a selective feature of human circulating antigen-induced plasma cells synthesizing high-affinity antibodies. Blood
111: 741-749
[Abstract]
[Full Text]
-
Ryan, M. C., Hering, M., Peckham, D., McDonagh, C. F., Brown, L., Kim, K. M., Meyer, D. L., Zabinski, R. F., Grewal, I. S., Carter, P. J.
(2007). Antibody targeting of B-cell maturation antigen on malignant plasma cells. Molecular Cancer Therapeutics
6: 3009-3018
[Abstract]
[Full Text]
-
Mantchev, G. T., Cortesao, C. S., Rebrovich, M., Cascalho, M., Bram, R. J.
(2007). TACI Is Required for Efficient Plasma Cell Differentiation in Response to T-Independent Type 2 Antigens. J. Immunol.
179: 2282-2288
[Abstract]
[Full Text]
-
Minges Wols, H. A., Ippolito, J. A., Yu, Z., Palmer, J. L., White, F. A., Le, P. T., Witte, P. L.
(2007). The effects of microenvironment and internal programming on plasma cell survival. Int Immunol
0: dxm051v1-
[Abstract]
[Full Text]
-
Kawasaki, A., Tsuchiya, N., Ohashi, J., Murakami, Y., Fukazawa, T., Kusaoi, M., Morimoto, S., Matsuta, K., Hashimoto, H., Takasaki, Y., Tokunaga, K.
(2007). Role of APRIL (TNFSF13) polymorphisms in the susceptibility to systemic lupus erythematosus in Japanese. Rheumatology (Oxford)
46: 776-782
[Abstract]
[Full Text]
-
Sakurai, D., Hase, H., Kanno, Y., Kojima, H., Okumura, K., Kobata, T.
(2007). TACI regulates IgA production by APRIL in collaboration with HSPG. Blood
109: 2961-2967
[Abstract]
[Full Text]
-
Chiu, A., Xu, W., He, B., Dillon, S. R., Gross, J. A., Sievers, E., Qiao, X., Santini, P., Hyjek, E., Lee, J.-w., Cesarman, E., Chadburn, A., Knowles, D. M., Cerutti, A.
(2007). Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL. Blood
109: 729-739
[Abstract]
[Full Text]
-
Schwaller, J., Schneider, P., Mhawech-Fauceglia, P., McKee, T., Myit, S., Matthes, T., Tschopp, J., Donze, O., Le Gal, F.-A., Huard, B.
(2007). Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness. Blood
109: 331-338
[Abstract]
[Full Text]
-
Mhawech-Fauceglia, P., Kaya, G., Sauter, G., McKee, T., Donze, O., Schwaller, J., Huard, B.
(2006). The source of APRIL up-regulation in human solid tumor lesions. J. Leukoc. Biol.
80: 697-704
[Abstract]
[Full Text]
-
Gilbert, J. A., Kalled, S. L., Moorhead, J., Hess, D. M., Rennert, P., Li, Z., Khan, M. Z., Banga, J. P.
(2006). Treatment of Autoimmune Hyperthyroidism in a Murine Model of Graves' Disease with Tumor Necrosis Factor-Family Ligand Inhibitors Suggests a Key Role for B Cell Activating Factor in Disease Pathology. Endocrinology
147: 4561-4568
[Abstract]
[Full Text]
-
Assou, S., Anahory, T., Pantesco, V., Le Carrour, T., Pellestor, F., Klein, B., Reyftmann, L., Dechaud, H., De Vos, J., Hamamah, S.
(2006). The human cumulus-oocyte complex gene-expression profile. Hum Reprod
21: 1705-1719
[Abstract]
[Full Text]
-
Miller, J. P., Stadanlick, J. E., Cancro, M. P.
(2006). Space, Selection, and Surveillance: Setting Boundaries with BLyS.. J. Immunol.
176: 6405-6410
[Abstract]
[Full Text]
-
Mongini, P. K. A., Inman, J. K., Han, H., Fattah, R. J., Abramson, S. B., Attur, M.
(2006). APRIL and BAFF Promote Increased Viability of Replicating Human B2 Cells via Mechanism Involving Cyclooxygenase 2.. J. Immunol.
176: 6736-6751
[Abstract]
[Full Text]
-
Bossen, C., Ingold, K., Tardivel, A., Bodmer, J.-L., Gaide, O., Hertig, S., Ambrose, C., Tschopp, J., Schneider, P.
(2006). Interactions of Tumor Necrosis Factor (TNF) and TNF Receptor Family Members in the Mouse and Human. J. Biol. Chem.
281: 13964-13971
[Abstract]
[Full Text]
-
Bischof, D., Elsawa, S. F., Mantchev, G., Yoon, J., Michels, G. E., Nilson, A., Sutor, S. L., Platt, J. L., Ansell, S. M., von Bulow, G., Bram, R. J.
(2006). Selective activation of TACI by syndecan-2. Blood
107: 3235-3242
[Abstract]
[Full Text]
-
Matsumoto, T., Abe, M.
(2006). Myeloma-Bone Interaction: A Vicious Cycle. IBMS BoneKEy
3: 8-14
[Abstract]
[Full Text]
-
Chang, Y.-C., Chan, Y.-H., Jackson, D. G., Hsieh, S.-L.
(2006). The Glycosaminoglycan-Binding Domain of Decoy Receptor 3 Is Essential for Induction of Monocyte Adhesion. J. Immunol.
176: 173-180
[Abstract]
[Full Text]
-
Shapiro-Shelef, M., Lin, K.-I, Savitsky, D., Liao, J., Calame, K.
(2005). Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow. JEM
202: 1471-1476
[Abstract]
[Full Text]